Integrating ECG signal features with the Framingham risk score significantly improved cardiovascular disease risk prediction in women, increasing the C-index from 0.84 to 0.85 with an NRI of 55.7%.
Cohort (n=4,637)
No
Does integrating ECG signal features into the Framingham Risk Score improve the prediction of incident cardiovascular disease in adults without prior CVD?
Effect estimate: NRI 55.7% (95% CI 46.5-65.0)
Absolute Event Rate: 0.85% vs 0.84%
p-value: p=<0.001
Non-communicable diseases (NCDs), particularly cardiovascular diseases (CVDs), have become the leading cause of mortality worldwide, with Iran exhibiting higher-than-average incidence and mortality rates. Early detection of high-risk individuals is critical, as CVD often progresses silently. Electrocardiogram (ECG) signals may enhance risk prediction beyond Framingham risk score (FRS). This study aimed to evaluate the predictive performance of ECG signal features for incident CVD using signal processing in a large population-based cohort from the Tehran Lipid and Glucose Study (TLGS). A total of 4,637 adults aged 40 years devoid of past CVD at baseline (2006-2008) were followed up until 2018. Baseline characteristics, laboratory measurements, and ECG signal features were collected. CVD events were defined as coronary heart disease (CHD) or stroke. A recalibrated FRS (baseline) model assessed the association between ECG features and incident CVD, with model performance evaluated using Harrell's C-index, Net Reclassification Index (NRI), and Integrated Discrimination Improvement (IDI). Over a 10-year follow-up, 483 participants (10.4%) developed CVD. The introduction of ECG signal features improved risk prediction in women, increasing the Harrell's C-index from 0.84 to 0.85 and demonstrating significant reclassification improvement (NRI: 55.7%, IDI: 2.8%). However, no meaningful improvement was observed in men. ECG-based modeling outperformed FRS, particularly for intermediate-risk categories among women. Incorporating ECG signal features into risk models significantly enhanced CVD prediction performance in women, suggesting potential utility for improving individualized preventive strategies. Further research is warranted to refine ECG-based risk stratification tools for broader clinical application.
Mahdavi et al. (Fri,) conducted a cohort in Cardiovascular disease (n=4,637). ECG signal features + Framingham risk score vs. Framingham risk score alone was evaluated on Incident CVD prediction performance (Harrell's C-index) in women (NRI 55.7%, 95% CI 46.5-65.0, p=<0.001). Integrating ECG signal features with the Framingham risk score significantly improved cardiovascular disease risk prediction in women, increasing the C-index from 0.84 to 0.85 with an NRI of 55.7%.